|
|
|
Insider
Information: |
Braunstein Douglas L |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
3,704,541 |
|
Indirect Shares
|
35,908,536 |
|
|
Direct
Value |
$102,375,744 |
|
|
Indirect Value
|
$614,125,084 |
|
|
Total
Shares |
39,613,077 |
|
|
Total
Value |
$716,500,828 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
1
|
Stock
price went up :
|
3
|
1
|
Stock
price went down : |
6
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
-41.0%
|
14.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
JP Morgan Chase & Co |
JPM |
Chief Financial Officer |
2012-12-26 |
470,836 |
2012-12-26 |
109,479 |
Premium* |
|
Eagle Pharmaceuticals, Inc. |
EGRX |
Director |
|
0 |
2019-10-25 |
732,777 |
Premium* |
|
Corindus Vascular Robotics, Inc. |
CVRS |
Director |
2019-10-29 |
0 |
2019-10-29 |
0 |
Premium* |
|
Cardtronics Inc |
CATM |
10% Owner |
2018-02-21 |
0 |
2021-03-09 |
8,658,920 |
Premium* |
|
Cantaloupe Inc |
CTLP |
10% Owner |
2023-02-21 |
20,212 |
2023-02-21 |
9,270,694 |
Premium* |
|
Tivity Health Inc |
TVTY |
10% Owner |
|
0 |
2020-05-07 |
4,795,310 |
Premium* |
|
Talkspace, Inc |
TALK |
|
2024-03-01 |
3,213,493 |
2024-03-01 |
12,341,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-09-17 |
4 |
AS |
$60.00 |
$6,000 |
I/I |
(100) |
810,365 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-08 |
4 |
AS |
$60.03 |
$93,520 |
I/I |
(1,558) |
803,906 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-09-11 |
4 |
AS |
$60.06 |
$66,785 |
I/I |
(1,112) |
810,665 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-09-12 |
4 |
AS |
$60.07 |
$12,014 |
I/I |
(200) |
810,465 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-07 |
4 |
AS |
$60.11 |
$294,600 |
I/I |
(4,901) |
805,464 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-10 |
4 |
AS |
$60.16 |
$471,002 |
I/I |
(7,829) |
796,077 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-11 |
4 |
AS |
$60.39 |
$984,419 |
I/I |
(16,300) |
779,777 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2019-10-16 |
4 |
AS |
$62.50 |
$6,375 |
I/I |
(102) |
775,766 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-24 |
4 |
AS |
$62.53 |
$93,412 |
I/I |
(1,494) |
748,214 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-21 |
4 |
AS |
$62.56 |
$240,791 |
I/I |
(3,849) |
756,475 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2019-10-17 |
4 |
AS |
$62.58 |
$866,196 |
I/I |
(13,842) |
761,924 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-23 |
4 |
AS |
$62.58 |
$12,516 |
I/I |
(200) |
749,708 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2019-10-18 |
4 |
AS |
$62.61 |
$100,174 |
I/I |
(1,600) |
760,324 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-15 |
4 |
AS |
$62.63 |
$244,836 |
I/I |
(3,909) |
775,868 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-22 |
4 |
AS |
$62.68 |
$411,618 |
I/I |
(6,567) |
749,908 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-25 |
4 |
AS |
$63.57 |
$981,302 |
I/I |
(15,437) |
732,777 |
0 |
- |
|
91 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|